Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Marta, Lomnytska"'
Autor:
Marta Lomnytska, Rui Pinto, Susanne Becker, Ulla Engström, Sonja Gustafsson, Christina Björklund, Markus Templin, Jan Bergstrand, Lei Xu, Jerker Widengren, Elisabeth Epstein, Bo Franzén, Gert Auer
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-14 (2018)
Abstract Background Platelets support cancer growth and spread making platelet proteins candidates in the search for biomarkers. Methods Two-dimensional (2D) gel electrophoresis, Partial Least Squares Discriminant Analysis (PLS-DA), Western blot, Dig
Externí odkaz:
https://doaj.org/article/a78fbd5add3142068516070e5e7250ad
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e555db701a6eb3f4375a9f612c8542f
https://doi.org/10.1136/ijgc-2022-esgo.581
https://doi.org/10.1136/ijgc-2022-esgo.581
Autor:
Enroth, Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma Ivansson, Marta Lomnytska, Maria Lycke, Tomas Axelsson, Ulrika Liljedahl, Jessica Nordlund, Per-Henrik Edqvist, Tobias Sjöblom, Mathias Uhlén, Karin Stålberg, Karin Sundfeldt, Mikael Åberg, Stefan
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1757
Background: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30–50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::7997062caa4007b64bd309bb24764f67
Autor:
Ulf, Gyllensten, Julia, Hedlund-Lindberg, Johanna, Svensson, Johanna, Manninen, Torbjörn, Öst, Jon, Ramsell, Matilda, Åslin, Emma, Ivansson, Marta, Lomnytska, Maria, Lycke, Tomas, Axelsson, Ulrika, Liljedahl, Jessica, Nordlund, Per-Henrik, Edqvist, Tobias, Sjöblom, Mathias, Uhlén, Karin, Stålberg, Karin, Sundfeldt, Mikael, Åberg, Stefan, Enroth
Publikováno v:
Cancers. 14(7)
Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30-50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7c55daac456c6832e520aad4ab1e55c
https://pubmed.ncbi.nlm.nih.gov/35406529
https://pubmed.ncbi.nlm.nih.gov/35406529
Publikováno v:
Annals of Surgical Oncology
Background Extent of tumor load is an important factor in the selection of ovarian cancer patients for cytoreductive surgery (CRS). The Peritoneal Cancer Index (PCI) gives exact information on tumor load but still is not standard in ovarian cancer su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a541cf005bf0625525a7a86fef3c67b4
https://doi.org/10.1245/s10434-020-08649-6
https://doi.org/10.1245/s10434-020-08649-6
Autor:
E Karlsson, Marta Lomnytska, Gert Auer, Jerker Widengren, Fariborz Mobarrez, Elisabeth Epstein
Publikováno v:
Ovarian cancer.
Introduction/Background* Routine blood markers provide poor diagnostic capacity for ovarian cancer. Ultrasound examination using the criteria developed by International Ovarian Tumor Analysis group is the most sensitive and specific diagnostic method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05f8cc3606806166448e3b1e077bd184
https://doi.org/10.1136/ijgc-2021-esgo.406
https://doi.org/10.1136/ijgc-2021-esgo.406
Autor:
Ilvars Silins, Marta Lomnytska, Karin Stålberg, Wilhelm Graf, Inger Sundström Poromaa, Björg Jónsdóttir, Evelina Karlsson, Ann-Marie Lejon
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 47(11)
Introduction prediction and importance of severe postoperative complications after ovarian cancer surgery is a strong issue in patient selection and evaluation. Pre- and early peroperative predictors of severe 30-days postoperative complications (Cla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cfad7315cec8da97af965d09ccb53b8
https://pubmed.ncbi.nlm.nih.gov/34053777
https://pubmed.ncbi.nlm.nih.gov/34053777
Publikováno v:
ePoster.
Introduction/Background Extent of tumour load is one of the important factors selecting patients with advanced ovarian cancer for cytoreductive surgery (CRS). Peritoneal cancer index (PCI) gives exact information on tumour distribution and is a progn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a676431dfcf21d315ebbc757286915fc
https://doi.org/10.1136/ijgc-2019-esgo.927
https://doi.org/10.1136/ijgc-2019-esgo.927
Publikováno v:
ePoster.
Introduction/Background Survival benefit of the repeated intraperithoneal chemotherapy after surgery was demonstrated in GOG studied for ovarian cancer patients. However, catheter-related complications and accumulated toxicity made the procedure non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::176dfda99470b651d5ed40390c650328
https://doi.org/10.1136/ijgc-2019-esgo.953
https://doi.org/10.1136/ijgc-2019-esgo.953
Autor:
Nailin Li, Ozan Öktem, Jan Bergstrand, Xinyan Miao, Lei Xu, Gert Auer, Marta Lomnytska, Bo Franzén, Jerker Widengren
Publikováno v:
Nanoscale. 11(20)
Protein contents in platelets are frequently changed upon tumor development and metastasis. However, how cancer cells can influence protein-selective redistribution and release within platelets, thereby promoting tumor development, remains largely el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3951f1eab6b5556af94fab816f9352
https://pubmed.ncbi.nlm.nih.gov/31086875
https://pubmed.ncbi.nlm.nih.gov/31086875